A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Mahalingam D, Owonikoko TK, Delpassand E, Mulcahy MF, et al. Cancer 2025;131:e35680.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mahalingam D, Owonikoko TK, Delpassand E, Mulcahy MF, et al. A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancers. Cancer 2025;131:e35680.
PMID: 39748726